Filament’s Novo Nordisk NVO Stock Holding History

Filament’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-8,250	Closed	-$224K	–	49
2016 Q1	$224K	Sell	8,250 -2,240	-21%	-$60K	0.11%	56
2015 Q4	$305K	Buy	+10,490	New	+$290K	0.15%	46

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Filament's NVO Position: Q2 2016 in Review

Filament sold out of Novo Nordisk (NVO) in Q2 2016, closing a stake of 8,250 shares — an estimated $224K sold.

Filament first reported a position in NVO in Q4 2015 and held it in 2 quarters. The position peaked at $305K in Q4 2015. 530 funds tracked by Wall St. Rank hold NVO as of Q2 2016.

Filament reported no remaining Novo Nordisk position as of Q2 2016 after selling out during the quarter.
Filament sold 8,250 Novo Nordisk shares in Q2 2016, an estimated $224K.
Filament first reported a position in Novo Nordisk in Q4 2015 and held it in 2 quarters.
Filament's Novo Nordisk position peaked at $305K in Q4 2015.
530 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2016.

Based on Filament's 13F filing for Q2 2016, filed 28 Jul 2016.